在滥用大麻后出现早期前性痴呆症:一个病例报告
Reza Moshfeghinia1,2,3, Bahare Oji2, Mehrnaz Hosseinzadeh4
1Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
BMC psychiatry
|June 30, 2023
概括
大麻使用可能会导致前部疾病 (FTD),一种神经退行性疾病. 这项案例研究强调了大麻滥用对大脑健康的潜在影响,促使对大麻和FTD进行进一步的研究.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 精神病学是一个精神病学.
背景情况:
- 前性疾病 (FTD) 是由于前和叶神经元损伤造成的.
- 目前,FTD还没有确定的治疗方法.
- 大麻素产品显示出治疗FTD耐药性行为变体 (bvFTD) 的管理潜力.
研究的目的:
- 介绍一个可能患有FTD的年轻男性的案例研究.
- 调查长期大麻滥用与FTD发展之间的潜在联系.
- 突出大麻对大脑结构和功能的神经毒性影响.
主要方法:
- 一个34岁的男性的案例报告,他有两年的大麻滥用史.
- 临床评估行为症状,包括冷漠,奇怪的行为和抑制.
- 对神经成像发现的审查,以支持可能的FTD的诊断.
主要成果:
- 患者呈现出与FTD一致的渐进性行为变化.
- 临床症状和成像结果表明FTD诊断可能存在.
- 这一案例强调了大麻消费可能影响大脑健康的潜力.
结论:
- 虽然大麻可能有助于管理痴呆症症状,但这一案例表明,大麻也可能导致FTD等神经退行性疾病.
- 长期滥用大麻可能对大脑化学和结构产生深远影响.
- 需要进一步的研究来了解大麻使用和FTD之间的复杂关系.
相关概念视频
Dementia
141
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
141
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
265
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
265
Alzheimer's Disease: Overview
527
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
527
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
324
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
324
Drug Abuse and Addiction: Pharmacological Phenomena
552
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
552
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K


